Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest NuvOx Pharma LLC Stories

2013-12-05 23:31:06

RiboMed Biotechnologies, Inc. and NuvOx Pharma today jointly announced that they have entered into a collaborative agreement that will utilize RiboMed’s epigenetic biomarker test, GliomaSTRAT™, to characterize tumors from brain cancer patients and correlate response to NuvOx’s new drug, NVX-108 in the treatment of Glioblastoma multiforme (GBM). Carlsbad, CA and Tucson, AZ (PRWEB) December 05, 2013 RiboMed Biotechnologies, Inc. and NuvOx Pharma today jointly announced that they have...